Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
-115.36%
Operating Margin
71.29%
Net Margin
312.21%
Efficiency Metrics
Revenue per Expense Ratio
0.47
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
312.15%
Income Tax Rate
0.00%
EPS
0.8100000000
Balance Sheet Analysis
Current Ratio
0.07
Cash Ratio
0.01
Working Capital
$-36.33M
Debt to Equity
0.00
Debt to Assets
0.00%
Equity Ratio
97.69%
Cash Flow Analysis
Operating Cash Flow Ratio
287.61%
Free Cash Flow Ratio
287.61%
CapEx to Revenue
0.00%
Dividends Paid
$135.28M
Stock Buybacks
$2.74M
Total Shareholder Returns
$138.02M
Cash Position Change
110.76%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
167.49%
Net Income
306.31%
EPS
307.69%
Operating Income
147.11%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
38.39%
Operating Cash Flow
-31.60%
Free Cash Flow
-31.60%
Balance Sheet Health
Assets
2.06%
Debt
0.00%
Book Value per Share
0.89%
Inventory
-100.02%
Shareholder Returns
Dividends per Share
-33.07%
Shares Outstanding
-0.15%
Long Term Trends
3Y Revenue/Share
386.52%
5Y Revenue/Share
139.29%
3Y Dividend/Share
19.24%
5Y Dividend/Share
29.68%